Product Information
TELMISARTAN 40 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.1536 per EA under NDC 00378292193. Its NADAC has been published 624 times since Sep 10, 2014.
FDA first approved this application on Jul 7, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378292193
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
TELMISARTANApproval Type
Generic (ANDA)
FDA Application
ANDA202397FDA Approved
7/7/2014
TE Code
AB
On Market Since
7/7/2014
Pharmacological Classes
Price Statistics
The NADAC for TELMISARTAN 40 MG TABLET has been published 624 times since Sep 10, 2014, and over the history we have for it it has declined 95.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1536 per EA |
|---|---|
| All-time high | $3.3682 (Sep 10, 2014) |
| All-time low | $0.1274 (Nov 20, 2024) |
| 52-week high | $0.1808 |
| 52-week low | $0.1519 |
| Median price | $0.3987 |
| Average price | $0.4199 |
| Largest weekly change | -58.3% (Nov 19, 2014) |
| Weeks tracked | 624 |
| Tracking since | Sep 10, 2014 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TELMISARTAN 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TELMISARTAN 40 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.1536 per EA (NDC 00378292193), effective Aug 19, 2026.
How has the price of TELMISARTAN 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for TELMISARTAN 40 MG TABLET has declined 95.4%. It has been tracked across 624 weekly CMS publications since Sep 10, 2014.
What are the highest and lowest recorded NADAC prices for TELMISARTAN 40 MG TABLET?
Since Sep 10, 2014, the NADAC for TELMISARTAN 40 MG TABLET has ranged from a low of $0.1274 (Nov 20, 2024) to a high of $3.3682 (Sep 10, 2014), with a median of $0.3987 per EA.
Are there cheaper alternatives to TELMISARTAN 40 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TELMISARTAN 40 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures TELMISARTAN 40 MG TABLET?
TELMISARTAN 40 MG TABLET (NDC 00378292193) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.